# Phytochemical Composition and Antioxidant and Anti‐Inflammatory Activities of Iningai Aboriginal Medicinal Plants From Central Queensland, Australia

**Authors:** Gerry Turpin, Darren Crayn, Suzanne Thompson, Karma Yeshi, Phurpa Wangchuk

PMC · DOI: 10.1155/sci5/5727253 · Scientifica · 2026-03-01

## TL;DR

This study validates the traditional use of eight medicinal plants by the Iningai people in Australia, showing they have antioxidant and anti-inflammatory properties.

## Contribution

Scientific validation of traditional Iningai medicinal plants through phytochemical and biological activity analysis.

## Key findings

- Seven of eight plant extracts significantly suppressed proinflammatory cytokines in PBMCs.
- Phytochemical screening identified alkaloids, phenolics, flavonoids, and terpenoids in the plant extracts.
- Pittosporum angustifolium showed high cytotoxicity with 73.97% cell death in human PBMCs.

## Abstract

Indigenous Australians possess vast ethnopharmacological knowledge of native flora and have been using it for millennia. In a collaborative initiative to document and scientifically validate this knowledge, the Tropical Indigenous Ethnobotany Centre, Australian Tropical Herbarium and the James Cook University have been working closely with traditional custodians from the Iningai community near Barcaldine, Queensland. This study aimed to evaluate crude leaf extracts from eight medicinal plant species traditionally used by the Iningai people, focusing on their phytochemical profile, antioxidant potential, cytotoxicity and anti‐inflammatory activity. Phytochemical screening confirmed the presence of alkaloids, phenolics, flavonoids and terpenoids. Antioxidant activity, assessed via the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) free radical scavenging assay, showed moderate to strong activity, with IC50 values ranging from 37.37 ± 1.01 μg/mL to 206.50 ± 2.44 μg/mL. Cell viability assay using human peripheral blood mononuclear cells (PBMCs) showed that Pittosporum angustifolium exhibited the highest cytotoxicity, resulting 73.97% cell death, suggesting potential toxicity to human cells. Anti‐inflammatory activity was evaluated in lipopolysaccharide (LPS)‐stimulated PBMCs. Seven of the eight plant extracts significantly suppressed the release of proinflammatory cytokines, including tumour necrosis factor (TNF), interferon‐gamma (IFN‐γ), monocyte chemoattractant protein‐1 (MCP‐1) and interleukin (IL)‐23. Overall, this study provides scientific validation for the traditional use of these eight medicinal plants by the Iningai people. The identification of key phytochemicals, antioxidant potential and anti‐inflammatory properties supports their ethnopharmacological relevance. Further investigation is warranted to isolate and characterise the active compounds from the most promising species for potential development into novel therapeutic agents.

## Linked entities

- **Chemicals:** 2,2-diphenyl-1-picrylhydrazyl (PubChem CID 2735032)
- **Species:** Pittosporum angustifolium (taxon 317700)

## Full-text entities

- **Genes:** IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, IL37 (interleukin 37) [NCBI Gene 27178] {aka FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H, IL-1H4}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}
- **Diseases:** atherosclerosis (MESH:D050197), TPC (MESH:C537895), arthritis (MESH:D001168), rheumatoid arthritis (MESH:D001172), cytotoxic (MESH:D064420), digestive disorders (MESH:D004066), Proinflammatory Cytokines (MESH:D000080424), breast cancer (MESH:D001943), IBDs (MESH:D015212), urinary bladder carcinoma (MESH:D001749), glioblastoma IV (MESH:D005909), pain (MESH:D010146), Inflammatory (MESH:D007249), diseases (MESH:D004194), neurodegenerative diseases (MESH:D019636), wounds (MESH:D014947), bowel disorders (MESH:D012778), cancer (MESH:D009369), diabetes (MESH:D003920), ankylosing spondylitis (MESH:D013167), autoimmune diseases (MESH:D001327)
- **Chemicals:** penicillin (MESH:D010406), Crude (-), acetic anhydride (MESH:C031800), tannin (MESH:D013634), golimumab (MESH:C529000), lignans (MESH:D017705), Dexa (MESH:D003907), isoquercitrin (MESH:C016527), phosphotungstic acids (MESH:D010772), lipids (MESH:D008055), Chloroform (MESH:D002725), LPS (MESH:D008070), Na2CO3 (MESH:C005686), (poly) phenols (MESH:D059808), certolizumab (MESH:D000068582), Aluminium chloride (MESH:D000077410), Steroid (MESH:D013256), CO2 (MESH:D002245), flavonoid (MESH:D005419), DMSO (MESH:D004121), ether (MESH:D004986), sulphuric acid (MESH:C033158), Saponin (MESH:D012503), glycoside (MESH:D006027), PBS (MESH:D007854), hydrogen (MESH:D006859), alcohols (MESH:D000438), Gallic acid (MESH:D005707), ammonia (MESH:D000641), Methanol (MESH:D000432), stilbenes (MESH:D013267), ferric chloride (MESH:C024555), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), rutin (MESH:D012431), streptomycin (MESH:D013307), nitrogen (MESH:D009584), phenolic acids (MESH:C017616), BHT (MESH:D002084), Cardiac Glycoside (MESH:D002301), Terpenoid (MESH:D013729), water (MESH:D014867), adalimumab (MESH:D000068879), free radicals (MESH:D005609), NO (MESH:D009569), ethanol (MESH:D000431), resveratrol (MESH:D000077185), HCl (MESH:D006851), acetic acid (MESH:D019342), alkaloid (MESH:D000470)
- **Species:** Pittosporum angustifolium (species) [taxon 317700], Linochilus tenuifolius (species) [taxon 587524], Acacia (genus) [taxon 3808], Homo sapiens (human, species) [taxon 9606], Santalum lanceolatum (blue bush, species) [taxon 453083], Petalostigma pubescens (species) [taxon 256815], Goodenia macrocalyx (species) [taxon 1697939], Gossypium australe (species) [taxon 47621], Dodonaea tenuifolia (species) [taxon 884410]
- **Cell lines:** LN18 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0392), 5637 — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_0126), MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12951002/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12951002/full.md

## References

105 references — full list in the complete paper: https://tomesphere.com/paper/PMC12951002/full.md

---
Source: https://tomesphere.com/paper/PMC12951002